PharmGen Science

PharmGen Science Years Dividend Increased

Years of Consecutive Dividend Increases of PharmGen Science (004720.KS) as of Nov 4, 2026.

Years Dividend Increased

0

Last updated:

Years of Consecutive Dividend Increases of PharmGen Science is 2025 0 . Years of Consecutive Dividend Increases of PharmGen Science was 2024 0.00 . It decreases by % lower compared to the previous year.

The PharmGen Science Years Dividend Increased history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Years Dividend Increased
Date
Years Dividend Increased
Jan 1, 2018
0.00 KRW
Jan 1, 2019
0.00 KRW
Jan 1, 2020
0.00 KRW
Jan 1, 2021
0.00 KRW
Jan 1, 2022
0.00 KRW
Jan 1, 2023
0.00 KRW
Jan 1, 2024
0.00 KRW
Jan 1, 2025
0.00 KRW
The PharmGen Science Years Dividend Increased history
YEARYears Dividend IncreasedYoY
0—
0—
0—
0—
0—
0—
0—
0—
0—
0—
0—
0—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PharmGen Science Stock analysis

What does PharmGen Science do? PharmGen Science, Inc. develops and produces medicaments including antiepileptic agents, anti-inflammatory agents, antiphlogistic agents, central nervous system agents, urinary agents, antihistamine agents, antivirus agents, agents for bones, agents for livers, calcium agents, antibiotics, diabetes agents, and respiratory agents. The company also manufactures over-the-counter (OTC) drugs, obesity drugs, and health food. Additionally, PharmGen Science engages in the manufacturing, wholesale, and retail distribution of functional cosmetics. Its products are distributed within the domestic market and to overseas markets. The company's primary revenue streams come from the sale of its pharmaceutical products and functional cosmetics. Pharmaceutical products include both prescription medications like antiepileptic agents and OTC drugs such as obesity drugs. Functional cosmetics are sold through wholesale and retail channels. The domestic market serves as the main sales channel while international distribution supports global reach. PharmGen Science targets healthcare providers, pharmacies, and consumers for its pharmaceutical products. The domestic market is a key segment for prescription drugs and OTC products. Overseas markets represent an additional segment for both pharmaceuticals and cosmetics. Functional cosmetics are distributed through retail and wholesale channels to end consumers and beauty retailers. PharmGen Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmGen Science stock

On Eulerpool you can find the complete historical development of Years of Consecutive Dividend Increases PharmGen Science since 2006 – with annual values, charts, and detailed analysis.

This measures how many consecutive years the dividend has been raised. Companies with 25+ years are considered Dividend Aristocrats.

Years of Consecutive Dividend Increases's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Years of Consecutive Dividend Increases's PharmGen Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — PharmGen Science

All Key Metrics — PharmGen Science